Extended Endocrine system
NSABP B-42 Trial shows MammaPrint Low Risk is Predictive of EET – JCO Publication
Journal of Clinical Oncology, July 24, 2024 Authors: Rastogi, et al.
Read MoreExtended Endocrine system
Journal of Clinical Oncology, July 24, 2024 Authors: Rastogi, et al.
Read MoreIDEAL Trial, GS5-10, SABCS 2022 Authors: Liefers, et al.
Read MoreJournal of Clinical Oncology, 40:4071-4082 Authors: Johansson et al.
Read MoreNSABP B-42 Trial, ASCO 2021 Abstract #502 Authors: Rastogi, et al.
Read More